Search

Displaying results 8511 - 8520 of 10000 in total
  1. Drug

    PHB-050

    go.drugbank.com/drugs/DB32061
    Experimental

    PHB-050 is a novel, next-generation anti-IgE antibody designed to block IgE from binding to mast cells, while also rapidly reducing circulating IgE and inhibiting its production. … [L54988] It is under investigation for the treatment of multiple atopic diseases, including food allergies, asthma, and atopic dermatitis.[L54988]

  2. Drug

    Zamubafusp alfa

    go.drugbank.com/drugs/DB32269
    Investigational

    Zamubafusp alfa is an immunoglobulin-peptide fusion protein.[L55038] It consists of a humanized IgG1 and p5R which is a pan-amyloid reactive peptide.[L55038]

  3. Drug

    YMI024

    go.drugbank.com/drugs/DB32602
    Experimental

    YMI024 is a drug being investigated for inflammation-driven diseases.[L56081]

  4. Drug

    SI-109

    go.drugbank.com/drugs/DB32603
    Experimental

    SI-109 is a potent, small-molecule inhibitor of the STAT3 SH2 domain.[A275443]

  5. Drug

    GLB-001

    go.drugbank.com/drugs/DB32795
    Investigational

    GLB-001 is a orally bioavailable molecular glue degrader targeting casein kinase 1 alpha (CK1a).[L56124, L56125, L56126]

  6. Drug

    Lys-plasminogen

    go.drugbank.com/drugs/DB32870
    Experimental

    Lys-plasminogen is a truncated form of natural human plasminogen.

  7. Drug

    Zolimomab aritox

    go.drugbank.com/drugs/DB33667
    Experimental

    Synonyms: Xoma zyme h 65, Orthozyme cd 5 plusCategories: N-Glycosyl Hydrolases, Ribosome Inactivating Proteins, Type 2
  8. Drug

    ONCOLYSIN B

    go.drugbank.com/drugs/DB33671
    Experimental

    Synonyms: ONCOLYSIN BCategories: N-Glycosyl Hydrolases, Ribosome Inactivating Proteins, Type 2
  9. Drug

    Lm-LLO-TT

    go.drugbank.com/drugs/DB33966
    Experimental

    Lm-LLO-TT is a biologic drug. Lm-LLO-TT is under investigation in clinical trial NCT07828236 (PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA).

  10. Drug

    SRN-101

    go.drugbank.com/drugs/DB33962
    Experimental

    SRN-101 is a biologic drug. … SRN-101 is under investigation in clinical trial NCT07826949 (A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.).